ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in Louisville, KY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Kidney Diseases
Chronic Renal Insufficiency
Chronic Kidney Failure
IGA Glomerulonephritis
Renal Cell Carcinoma
Renal Insufficiency
Carcinoma

Kidney Disease trials near Louisville, KY, USA:

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medici...

Begins enrollment in 1 month
Chronic Kidney Disease
Drug: Placebo
Drug: Empagliflozin

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Louisville, Kentucky, United States and 86 other locations

The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the cl...

Enrolling
Chronic Kidney Disease
Cardiac Disease
Drug: Placebo
Drug: Ravulizumab

Phase 3

Alexion Pharmaceuticals
Alexion Pharmaceuticals

Louisville, Kentucky, United States and 213 other locations

of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Chronic Kidney Disease (CKD)
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

Louisville, Kentucky, United States and 840 other locations

with end stage kidney disease (ESKD) undergoing maintenance dialysis....

Enrolling
Atherosclerotic Cardiovascular Disease
Atherosclerotic Cardiovascular Disease in Patients With ESKD
Drug: CSL300
Drug: Placebo

Phase 2, Phase 3

CSL Behring
CSL Behring

Louisville, Kentucky, United States and 340 other locations

The ALIGN Study is a phase 3, double-blind, placebo-controlled study to compare the efficacy and safety of atrasentan to placebo in patients with IgA...

Active, not recruiting
Immunoglobulin A Nephropathy
IgA Nephropathy
Drug: Placebo
Drug: Atrasentan

Phase 3

Chinook Therapeutics

Louisville, Kentucky, United States and 135 other locations

The primary study objective is to evaluate the benefit of the Sirolimus eluting Collagen implant (SeCI; Sirogen), a single dose prophylactic treatmen...

Active, not recruiting
Chronic Kidney Failure
End Stage Renal Disease
Drug: Sirolimus

Phase 3

Vascular Therapies, Inc.

Louisville, Kentucky, United States and 21 other locations

(IG) for hemodialysis (HD) access in patients with end-stage renal disease (ESRD). The primary study endpoints are:Primary Effectiveness End...

Enrolling
Kidney Failure
Chronic Renal Disease
Device: InnAVasc Arteriovenous Graft (IG) surgical implant
W.L. Gore & Associates
W.L. Gore & Associates

Louisville, Kentucky, United States and 10 other locations

implicated in the inflammatory chemokine environment of chronic disease. The purpose of this pivotal randomized double-blind study is to inv...

Enrolling
FSGS
Drug: DMX-200
Drug: Placebo

Phase 3

Dimerix Bioscience

Louisville, Kentucky, United States and 219 other locations

The objectives of this study are to evaluate the safety and efficacy of ravulizumab administered by intravenous (IV) infusion compared to placebo and...

Active, not recruiting
Immunoglobulin A Nephropathy
Lupus Nephritis
Drug: Placebo
Drug: Ravulizumab

Phase 2

Alexion Pharmaceuticals
Alexion Pharmaceuticals

Louisville, Kentucky, United States and 63 other locations

Locations recently updated

The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabete...

Active, not recruiting
Chronic Kidney Disease
Cardiovascular Diseases
Drug: Orforglipron
Drug: Insulin Glargine

Phase 3

Lilly
Lilly

Louisville, Kentucky, United States and 370 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems